These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
574 related articles for article (PubMed ID: 24345703)
1. Changes of CD4+CD25+FOXP3+ and CD8+CD28- regulatory T cells in non-small cell lung cancer patients undergoing surgery. Chen C; Chen D; Zhang Y; Chen Z; Zhu W; Zhang B; Wang Z; Le H Int Immunopharmacol; 2014 Feb; 18(2):255-61. PubMed ID: 24345703 [TBL] [Abstract][Full Text] [Related]
2. CD8+CD28- cells and CD4+CD25+ regulatory T cells in the peripheral blood of advanced stage lung cancer patients. Karagöz B; Bilgi O; Gümüs M; Erikçi AA; Sayan O; Türken O; Kandemir EG; Oztürk A; Yaylaci M Med Oncol; 2010 Mar; 27(1):29-33. PubMed ID: 19148592 [TBL] [Abstract][Full Text] [Related]
3. Changes of regulatory T cells and FoxP3 gene expression in the aging process and its relationship with lung tumors in humans and mice. Pan XD; Mao YQ; Zhu LJ; Li J; Xie Y; Wang L; Zhang GB Chin Med J (Engl); 2012 Jun; 125(11):2004-11. PubMed ID: 22884069 [TBL] [Abstract][Full Text] [Related]
4. Regulatory CD4(+)CD25(+) T cells in tumors from patients with early-stage non-small cell lung cancer and late-stage ovarian cancer. Woo EY; Chu CS; Goletz TJ; Schlienger K; Yeh H; Coukos G; Rubin SC; Kaiser LR; June CH Cancer Res; 2001 Jun; 61(12):4766-72. PubMed ID: 11406550 [TBL] [Abstract][Full Text] [Related]
5. Increase of regulatory T cells in metastatic stage and CTLA-4 over expression in lymphocytes of patients with non-small cell lung cancer (NSCLC). Erfani N; Mehrabadi SM; Ghayumi MA; Haghshenas MR; Mojtahedi Z; Ghaderi A; Amani D Lung Cancer; 2012 Aug; 77(2):306-11. PubMed ID: 22608141 [TBL] [Abstract][Full Text] [Related]
6. Elevated Circulating CD4 Hu X; Gu Y; Zhao S; Hua S; Jiang Y Cancer Biother Radiopharm; 2019 Jun; 34(5):325-333. PubMed ID: 30925076 [No Abstract] [Full Text] [Related]
7. Suppressive effects of gemcitabine plus cisplatin chemotherapy on regulatory T cells in nonsmall-cell lung cancer. Chen C; Chen Z; Chen D; Zhang B; Wang Z; Le H J Int Med Res; 2015 Apr; 43(2):180-7. PubMed ID: 25659373 [TBL] [Abstract][Full Text] [Related]
8. Foxp3 expressing CD4+ CD25+ and CD8+CD28- T regulatory cells in the peripheral blood of patients with lung cancer and pleural mesothelioma. Meloni F; Morosini M; Solari N; Passadore I; Nascimbene C; Novo M; Ferrari M; Cosentino M; Marino F; Pozzi E; Fietta AM Hum Immunol; 2006; 67(1-2):1-12. PubMed ID: 16698419 [TBL] [Abstract][Full Text] [Related]
9. The frequency of regulatory CD3+CD8+CD28- CD25+ T lymphocytes in human peripheral blood increases with age. Simone R; Zicca A; Saverino D J Leukoc Biol; 2008 Dec; 84(6):1454-61. PubMed ID: 18780874 [TBL] [Abstract][Full Text] [Related]
10. [The subpopulation CD4(+); CD25(+); Foxp3(+);/CD127(low/-); regulatory T cells in peripheral blood of HIV-infected patients correlated with disease progression]. Chen YL; Chen XR; Qin LX; Yang YF; Tang YM Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2012 Nov; 28(11):1188-91. PubMed ID: 23127412 [TBL] [Abstract][Full Text] [Related]
11. Significance of immunoregulatory T cells in different stages of breast cancer patients. Abo-Elenein A; Elgohary SE; Hashish A; El-Halaby E Egypt J Immunol; 2008; 15(2):145-52. PubMed ID: 20306697 [TBL] [Abstract][Full Text] [Related]
12. [Clinical significance of CD4+ CD25+ regulatory T-cells detection in tumor-draining lymph nodes of nonsmall cell lung cancer patients]. Su YJ; Ren K; Li H; Ren XB; Wang CL Zhonghua Zhong Liu Za Zhi; 2007 Dec; 29(12):922-6. PubMed ID: 18478932 [TBL] [Abstract][Full Text] [Related]
14. CD4(+)CD25(+)CD127(low/-) regulatory T cells express Foxp3 and suppress effector T cell proliferation and contribute to gastric cancers progression. Shen LS; Wang J; Shen DF; Yuan XL; Dong P; Li MX; Xue J; Zhang FM; Ge HL; Xu D Clin Immunol; 2009 Apr; 131(1):109-18. PubMed ID: 19153062 [TBL] [Abstract][Full Text] [Related]
15. Phenotyping of lymphocytes expressing regulatory and effector markers in infiltrating ductal carcinoma of the breast. Leong PP; Mohammad R; Ibrahim N; Ithnin H; Abdullah M; Davis WC; Seow HF Immunol Lett; 2006 Feb; 102(2):229-36. PubMed ID: 16246429 [TBL] [Abstract][Full Text] [Related]
16. CD13+CD4+CD25hi regulatory T cells exhibit higher suppressive function and increase with tumor stage in non-small cell lung cancer patients. Ju S; Qiu H; Zhou X; Zhu B; Lv X; Huang X; Li J; Zhang Y; Liu L; Ge Y; Johnson DE; Ju S; Shu Y Cell Cycle; 2009 Aug; 8(16):2578-85. PubMed ID: 19597336 [TBL] [Abstract][Full Text] [Related]
18. Frequency and activation of CD4+CD25 FoxP3+ regulatory T cells in peripheral blood from children with atopic allergy. Stelmaszczyk-Emmel A; Zawadzka-Krajewska A; Szypowska A; Kulus M; Demkow U Int Arch Allergy Immunol; 2013; 162(1):16-24. PubMed ID: 23817221 [TBL] [Abstract][Full Text] [Related]
19. CD4+CD25+CD127-Foxp3+ and CD8+CD28- Tregs in Renal Transplant Recipients: Phenotypic Patterns, Association With Immunosuppressive Drugs, and Interaction With Effector CD8+ T Cells and CD19+IL-10+ Bregs. Aly MG; Ibrahim EH; Karakizlis H; Weimer R; Opelz G; Morath C; Zeier M; Ekpoom N; Daniel V Front Immunol; 2021; 12():716559. PubMed ID: 34335631 [TBL] [Abstract][Full Text] [Related]
20. Quantitative reduction of peripheral CD4+ CD25+ FOXP3+ regulatory T cells in reproductive failure after artificial insemination by donor sperm. Lu Y; Zhang F; Zhang Y; Zeng B; Hu L; Liao A Am J Reprod Immunol; 2013 Feb; 69(2):188-93. PubMed ID: 23173675 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]